Disseminated granuloma annulare - Treatment with fumaric acid esters

Dermatology

Volumn 210, Issue 3, 2005, Pages 223-226

  Eberlein Konig B ^a,b   Mempel, M ^a   Stahlecker, J ^b   Forer, I ^b   Ring, J ^b   Abeck, D ^b  

^a Div 'Environ Dermatol A   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Disseminated granuloma annulare; Fumaric acid esters

Indexed keywords

FUMARIC ACID ETHYL ESTER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG EFFICACY; FEMALE; FLUSHING; GRANULOMA ANNULARE; HUMAN; NAUSEA; PRIORITY JOURNAL; REMISSION; SIDE EFFECT; STANDARDIZATION; STOMACH PAIN; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADMINISTRATION, ORAL; ADULT; AGED; DERMATOLOGIC AGENTS; FEMALE; FUMARATES; GRANULOMA ANNULARE; HUMANS; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 17244374024     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083514     Document Type: Article

References (14)

1. Kreuter A, Gambichler T, Altmeyer P, Brockmeyer NH: Treatment of disseminated granuloma annulare with fumaric acid esters. BMC Dermatol 2002;2:5.
2. Schulze-Dirks A, Petzold D: Granuloma annulare disseminatum - Erfolgreiche Therapie mit Fumarsäureester. Hautarzt 2001;52:228-230.
3. Mempel M, Musette P, Flageul B, Schnopp C, Remling R, Gachelin G, Kourilsky P, Ring J, Abeck D: T-cell receptor repertoire and cytokine pattern in granuloma annulare: Defining a particular type of cutaneous granulomatous inflammation. J Invest Dermatol 2002;118: 957-966.
4. Altmeyer PJ, Matthes U, Pawlak F, Hoffmann K, Frosch PJ, Ruppert P, Wassilew SW, Horn T, Kreysel HW, Lutz G, Barth J, Rietzschel I, Joshi RK: Antipsoriatic effect of fumaric acid derivatives: Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol 1994;30:977-981.
5. Mrowietz U, Christophers E, Altmeyer P for the German fumaric acid ester consensus conference: Treatment of severe psoriasis with fumaric acid esters: Scientific background and guidelines for therapeutic use. Br J Dermatol 1999;141:424-429.
6. Mrowietz U, Christophers E, Altmeyer P and the participants in the German multicenter study: Treatment of psoriasis with fumaric acid esters: Results of a prospective multicentre study. Br J Dermatol 1998;138:456-460.
7. Gollnick H, Altmeyer P, Kaufmann R, Ring J, Christophers E, Pavel S, Ziegler J: Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris. Dermatology 2002;205:46-53.
8. Höxtermann S, Nüchel C, Altmeyer P: Fumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasis. Dermatology 1998;196:223-230.
9. de Jong R, Bezemer AC, Zomerdijk TP, van de Pouw-Kraan T, Ottenhoff TH, Nibbering PH: Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate. Eur J Immunol 1996;26:1067-1074.
10. Ockenfels HM, Schultewolter T, Ockenfels G, Funk R, Goos M: The anti-psoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network. Br J Dermatol 1998;139:390-395.
11. Fayyazi A, Schweyer S, Eichmeyer B, Herms J, Hemmerlein B, Radzun HJ, Berger H: Expression of IFNgamma, coexpression of TNFalpha and matrix metalloproteinases and apoptosis of T lymphocytes and macrophages in granuloma annulare. Arch Dermatol Res 2000;292:384-390.
12. Nowack U, Gambichler T, Hanefeld C, Kastner U, Altmeyer P: Successful treatment of recalcitrant cutaneous sarcoidosis with fumaric acid esters. BMC Dermatol 2002;2:15.
13. Gutzmer R, Breuer K, Kiehl P, Kapp A, Werfel T: Successful therapy of annular elastolytic giant cell granuloma with fumaric acid esters. Dermatology 2002;205:421-424.
14. Gambichler T, Kreuter A, Freitag M, Pawlak FM, Brockmeyer NH, Altmeyer P: Clearance of necrobiosis lipoidica with fumaric acid esters. Dermatology 2003;207:422-424.